Stryker’s 2018 sales increased 9.3 percent to $413.6 billion, with growth across all lines.
Johnson & Johnson subsidiary DePuy Synthes plans to create 30 new jobs at its Ireland hub because of a $41.16 million investment.
The FDA granted Zimmer Biomet 510(k) clearance for its ROSA Knee System.
Medtronic launched the Mazor X Stealth Edition in the U.S.
SpineGuard released its 2018 full-year financial report.
Globus Medical’s Secure-C Cervical Artificial Disc was granted expanded coverage by Anthem.
A U.S. Court of Appeals for the Federal Circuit affirmed a previous judgment in a patent infringement case that ordered Medtronic to pay millions of dollars to a spine surgeon.
Healthcare technology solutions provider Nextech Systems purchased SRS Health Software.
Aurora Spine received a U.S. patent related to its minimally invasive spine implants.
Johnson & Johnson and DePuy Orthopaedics settled ongoing litigation surrounding allegations the company used deceptive marketing claims for two metal-on-metal implants for $120 million.
The 1,000th patient completed one year of follow-up in X-Bolt Orthopaedics’ World Hip Trauma Evaluation 4 study.
Johnson & Johnson reported fourth quarter and full-year results for DePuy Synthes, its orthopedics division.
More articles on devices and implants:
2 Qs with OSSIO CEO Brian Verrier
DePuy Synthes creates new jobs in Ireland with investment: 3 details
Zimmer Biomet receives FDA approval for robotically-assisted knee system: 3 insights
